The role of HSP90 molecular chaperones in hepatocellular carcinoma
- PMID: 32452023
- DOI: 10.1002/jcp.29776
The role of HSP90 molecular chaperones in hepatocellular carcinoma
Abstract
Misfolded proteins have enhanced formation of toxic oligomers and nonfunctional protein copies lead to recruiting wild-type protein types. Heat shock protein 90 (HSP90) is a molecular chaperone generated by cells that are involved in many cellular functions through regulation of folding and/or localization of large multi-protein complexes as well as client proteins. HSP90 can regulate a number of different cellular processes including cell proliferation, motility, angiogenesis, signal transduction, and adaptation to stress. HSP90 makes the mutated oncoproteins able to avoid misfolding and degradation and permits the malignant transformation. As a result, HSP90 is an important factor in several signaling pathways associated with tumorigenicity, therapy resistance, and inhibiting apoptosis. Clinically, the upregulation of HSP90 expression in hepatocellular carcinoma (HCC) is linked with advanced stages and inappropriate survival in cases suffering from this kind of cancer. The present review comprehensively assesses HSP90 functions and its possible usefulness as a potential diagnostic biomarker and therapeutic option for HCC.
Keywords: chaperone proteins; heat shock protein 90; hepatocellular carcinoma; liver cancer.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.Mol Cancer. 2017 Dec 20;16(1):178. doi: 10.1186/s12943-017-0748-y. Mol Cancer. 2017. PMID: 29262861 Free PMC article.
-
HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma.Mol Med Rep. 2019 Jan;19(1):524-532. doi: 10.3892/mmr.2018.9667. Epub 2018 Nov 19. Mol Med Rep. 2019. PMID: 30483734
-
The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.Cell Biol Int. 2012 Oct 1;36(10):893-9. doi: 10.1042/CBI20110473. Cell Biol Int. 2012. PMID: 22694478
-
The Role of HSP90 and TRAP1 Targets on Treatment in Hepatocellular Carcinoma.Mol Biotechnol. 2025 Apr;67(4):1367-1381. doi: 10.1007/s12033-024-01151-4. Epub 2024 Apr 29. Mol Biotechnol. 2025. PMID: 38684604 Review.
-
[Relationship between abnormal expression of heat shock protein 90 and malignant transformation of hepatocytes].Zhonghua Gan Zang Bing Za Zhi. 2006 Apr;14(4):314-7. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16635315 Review. Chinese. No abstract available.
Cited by
-
AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers.Cancer Cell Int. 2024 Aug 12;24(1):283. doi: 10.1186/s12935-024-03455-6. Cancer Cell Int. 2024. PMID: 39135041 Free PMC article.
-
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.Front Pharmacol. 2024 Nov 5;15:1475998. doi: 10.3389/fphar.2024.1475998. eCollection 2024. Front Pharmacol. 2024. PMID: 39564119 Free PMC article. Review.
-
Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases.Mol Biotechnol. 2025 Aug;67(8):2997-3009. doi: 10.1007/s12033-024-01251-1. Epub 2024 Aug 20. Mol Biotechnol. 2025. PMID: 39162909 Review.
-
The Disassociation of the A20/HSP90 Complex via Downregulation of HSP90 Restores the Effect of A20 Enhancing the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents.Front Oncol. 2021 Dec 15;11:804412. doi: 10.3389/fonc.2021.804412. eCollection 2021. Front Oncol. 2021. PMID: 34976842 Free PMC article.
-
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites.Pharmaceuticals (Basel). 2025 Jan 3;18(1):50. doi: 10.3390/ph18010050. Pharmaceuticals (Basel). 2025. PMID: 39861113 Free PMC article.
References
REFERENCES
-
- Albrethsen, J., Miller, L. M., Novikoff, P. M., & Angeletti, R. H. (2011). Gel-based proteomics of liver cancer progression in rat. Biochimica et Biophysica Acta-Proteins Proteomics, 1814, 1367-1376. https://doi.org/10.1016/j.bbapap.2011.05.018
-
- Alexiou, G. A., Vartholomatos, G., Stefanaki, K., Patereli, A., Dova, L., Karamoutsios, A., … Prodromou, N. (2013). Expression of heat shock proteins in medulloblastoma. Journal of Neurosurgery Pediatrics, 12, 452-457. https://doi.org/10.3171/2013.7.peds1376
-
- Augello, G., Emma, M. R., Cusimano, A., Azzolina, A., Mongiovì, S., Puleio, R., … Cervello, M. (2019). Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma. International Journal of Cancer, 144, 2613-2624. https://doi.org/10.1002/ijc.31963
-
- Banz, V. M., Medová, M., Keogh, A., Furer, C., Zimmer, Y., Candinas, D., & Stroka, D. (2009). Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3β. Biochimica et Biophysica Acta-Molecular Cell Research, 1793, 1597-1603. https://doi.org/10.1016/j.bbamcr.2009.08.002
-
- Barrott, J. J., & Haystead, T. A. J. (2013). Hsp90, an unlikely ally in the war on cancer. FEBS Journal, 280, 1381-1396. https://doi.org/10.1111/febs.12147
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials